Wu Sheng-Jie, Zou Hai, Zhu Gui-Qi, Wang Li-Ren, Zhang Qi, Shi Ke-Qing, Han Ji-Bo, Huang Wei-Jian, Braddock Martin, Chen Yong-Ping, Zheng Ming-Hua
From the Department of Cardiovascular Medicine, the Heart Center, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou (SJW, QZ, JBH, WJH); Department of Internal Medicine, Xinyu People's Hospital of Jiangxi Province, Xinyu (HZ); Department of Infection and Liver Diseases, Liver Research Center, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou (GQZ, LRW, KQS, YPC, MHZ); School of the First Clinical Medical Sciences, Wenzhou Medical University, Wenzhou (GQZ, LRW); Institute of Hepatology, Wenzhou Medical University, Wenzhou, China (KQS, YPC, MHZ); Global Medicines Development, AstraZeneca R&D, Alderley Park, United Kingdom (MB).
Medicine (Baltimore). 2015 May;94(19):e842. doi: 10.1097/MD.0000000000000842.
A positive association between hypertension or high-normal blood pressure (BP) and risk of nonalcoholic fatty liver disease (NAFLD) is well-known; however, no data have been generated exploring the risk of NAFLD within the normal range of BP. We aimed to assess the association between normal systolic blood pressure (SBP) and risk of NAFLD.A total of 27,769 subjects from 2 separate medical centers were included. Subjects were divided into 4 groups (G1 to G4) by SBP levels: G1: 90-99 mmHg, G2: 100-109 mmHg, G3: 110-119 mmHg, and G4: 120-129 mmHg. The prevalence, hazard ratios (HRs) and 95% confidence intervals (CIs) for NAFLD were calculated across each group, using the G1 as reference.Higher SBP was observed in subjects with NAFLD than those without NAFLD. The prevalence of NAFLD in a cross-sectional population from G1 to G4 was 6.1%, 13.6%, 19.6%, and 25.8%, respectively. The HRs for NAFLD in the longitudinal population were 2.17 (95% CI 1.60-2.93), 3.87 (95% CI 2.89-5.16), 5.81 (95% CI 4.32-7.81) for G2, G3, and G4, respectively. After adjusting for known confounding variables, HRs of G2 to G4 were 1.44 (95% CI 1.06-1.96), 1.94 (95% CI 1.44-2.61), 2.38 (95% CI 1.75-3.23), respectively.This is the first study to demonstrate that increased levels of SBP within the normal range are associated with significantly elevated risks of NAFLD, independent of other confounding factors.
高血压或血压正常高值与非酒精性脂肪性肝病(NAFLD)风险之间的正相关关系已广为人知;然而,尚未有数据探讨血压正常范围内NAFLD的风险。我们旨在评估正常收缩压(SBP)与NAFLD风险之间的关联。
总共纳入了来自2个不同医疗中心的27769名受试者。根据SBP水平将受试者分为4组(G1至G4):G1:90 - 99 mmHg,G2:100 - 109 mmHg,G3:110 - 119 mmHg,G4:120 - 129 mmHg。以G1为参照,计算每组NAFLD的患病率、风险比(HRs)和95%置信区间(CIs)。
与无NAFLD的受试者相比,NAFLD受试者的SBP更高。横断面人群中G1至G4组NAFLD的患病率分别为6.1%、13.6%、19.6%和25.8%。纵向人群中G2、G3和G4组NAFLD的HRs分别为2.17(95% CI 1.60 - 2.93)、3.87(95% CI 2.89 - 5.16)、5.81(95% CI 4.32 - 7.81)。在对已知混杂变量进行校正后,G2至G4组的HRs分别为1.44(95% CI 1.06 - 1.96)、1.94(95% CI 1.44 - 2.61)、2.38(95% CI 1.75 - 3.23)。
这是第一项表明在正常范围内SBP升高与NAFLD风险显著升高相关的研究,且独立于其他混杂因素。